ALPINE GROUP PARTNERS, LLC.

Lobbying for AMGEN

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Medicare/Medicaid

Issues related to Part D rebates Proposals related to drug pricing, drug price transparency, PBMs Implementation of the Inflation Reduction Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.